|
82
|
298
|
2clxA |
4-arylazo-3,5-diamino-1h-pyrazole cdk inhibitors: sar study, crystal structure in complex with cdk2, selectivity, and cellular effects |
|
77
|
296
|
2c6mA |
Crystal structure of the human cdk2 complexed with the triazolopyrimidine inhibitor |
|
79
|
296
|
2c68A |
Crystal structure of the human cdk2 complexed with the triazolopyrimidine inhibitor |
|
81
|
298
|
2c69A |
Crystal structure of the human cdk2 complexed with the triazolopyrimidine inhibitor |
|
77
|
298
|
2c6kA |
Crystal structure of the human cdk2 complexed with the triazolopyrimidine inhibitor |
|
80
|
296
|
2c5nA |
Differential binding of inhibitors to active and inactive cdk2 provides insights for drug design |
|
77
|
298
|
2c6lA |
Crystal structure of the human cdk2 complexed with the triazolopyrimidine inhibitor |
|
71
|
298
|
2btsA |
Structure of cdk2 complexed with pnu-230032 |
|
90
|
302
|
2bpmA |
Structure of cdk2-cyclin a with pha-630529 |
|
80
|
298
|
2bheA |
Human cyclin dependent protein kinase 2 in complex with the inhibitor 5-bromo-indirubine |
|
69
|
298
|
2btrA |
Structure of cdk2 complexed with pnu-198873 |
|
91
|
302
|
2bkzA |
Structure of cdk2-cyclin a with pha-404611 |
|
78
|
298
|
2b52A |
Human cyclin dependent kinase 2 (cdk2) complexed with dph-042562 |
|
76
|
298
|
2bhhA |
Human cyclin dependent protein kinase 2 in complex with the inhibitor 4-hydroxypiperindinesulfonyl-indirubine |
|
75
|
298
|
2b54A |
Human cyclin dependent kinase 2 (ckd2)complexed with din-232305 |
|
79
|
298
|
2b55A |
Human cyclin dependent kinase 2 (cdk2) complexed with indenopyraxole din-101312 |
|
81
|
298
|
2b53A |
Human cyclin dependent kinase 2 (cdk2) complexed with din-234325 |
|
71
|
298
|
2a4lA |
Human cyclin-dependent kinase 2 in complex with roscovitine |
|
78
|
298
|
2a0cX |
Human cdk2 in complex with olomoucine ii, a novel 2,6,9-trisubstituted purine cyclin-dependent kinase inhibitor |
|
71
|
298
|
1y91A |
Crystal structure of human cdk2 complexed with a pyrazolo[1,5-a]pyrimidine inhibitor |
|
79
|
298
|
1y8yA |
Crystal structure of human cdk2 complexed with a pyrazolo[1,5-a]pyrimidine inhibitor |
|
78
|
298
|
1ykrA |
Crystal structure of cdk2 with an aminoimidazo pyridine inhibitor |
|
69
|
295
|
1xo2B |
Crystal structure of a human cyclin-dependent kinase 6 complex with a flavonol inhibitor, fisetin |
|
82
|
298
|
1w8cA |
Co-crystal structure of 6-cyclohexylmethoxy-8-isopropyl-9h-purin-2- ylamine and monomeric cdk2 |
|
76
|
298
|
1wccA |
Screening for fragment binding by x-ray crystallography |
|
79
|
298
|
1w0xC |
Crystal structure of human cdk2 in complex with the inhibitor olomoucine. |
|
83
|
298
|
1w98A |
The structural basis of cdk2 activation by cyclin e |
|
85
|
302
|
1vywA |
Structure of cdk2/cyclin a with pnu-292137 |
|
73
|
298
|
1vyzA |
Structure of cdk2 complexed with pnu-181227 |
|
73
|
298
|
1v1kA |
Cdk2 in complex with a disubstituted 4, 6-bis anilino pyrimidine cdk4 inhibitor |
|
73
|
284
|
1v0oA |
Structure of p. falciparum pfpk5-indirubin-5-sulphonate ligand complex |
|
80
|
286
|
1v0bA |
Crystal structure of the t198a mutant of pfpk5 |
|
79
|
298
|
1urwA |
Cdk2 in complex with an imidazo[1,2-b]pyridazine |
|
80
|
286
|
1v0pA |
Structure of p. falciparum pfpk5-purvalanol b ligand complex |
|
81
|
296
|
1urcA |
Cyclin a binding groove inhibitor ace-arg-lys-leu-phe-gly |
|
66
|
299
|
1ua2A |
Crystal structure of human cdk7 |
|
72
|
298
|
1r78A |
Cdk2 complex with a 4-alkynyl oxindole inhibitor |
|
85
|
297
|
1qmzA |
Phosphorylated cdk2-cyclyin a-substrate peptide complex |
|
81
|
298
|
1pxlA |
Human cyclin dependent kinase 2 complexed with the inhibitor [4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-(4-trifluoromethyl-phenyl)-amine |
|
79
|
298
|
1pw2A |
Apo structure of human cyclin-dependent kinase 2 |
|
82
|
298
|
1pxoA |
Human cyclin dependent kinase 2 complexed with the inhibitor [4-(2-amino-4-methyl-thiazol-5-yl)-pyrimidin-2-yl]-(3-nitro-phenyl)-amine |
|
73
|
298
|
1pyeA |
Crystal structure of cdk2 with inhibitor |
|
82
|
298
|
1pxmA |
Human cyclin dependent kinase 2 complexed with the inhibitor 3-[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-ylamino]-phenol |
|
76
|
298
|
1pxnA |
Human cyclin dependent kinase 2 complexed with the inhibitor 4-[4-(4-methyl-2-methylamino-thiazol-5-yl)-pyrimidin-2-ylamino]-phenol |
|
74
|
298
|
1pxjA |
Human cyclin dependent kinase 2 complexed with the inhibitor 4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-ylamine |
|
78
|
298
|
1pxkA |
Human cyclin dependent kinase 2 complexed with the inhibitor n-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-n'-hydroxyiminoformamide |
|
83
|
297
|
1pkdA |
The crystal structure of ucn-01 in complex with phospho-cdk2/cyclin a |
|
76
|
298
|
1pxiA |
Human cyclin dependent kinase 2 complexed with the inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2-ylamine |
|
76
|
298
|
1pxpA |
Human cyclin dependent kinase 2 complexed with the inhibitor n-[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-n',n'-dimethyl-benzene-1,4-diamine |
|
74
|
298
|
1p2aA |
The structure of cyclin dependent kinase 2 (ckd2) with a trisubstituted naphthostyril inhibitor |
